Prodromic
Prodromic is a company focused on early personalized prediction for brain health, specifically targeting neurological conditions like dementia and Alzheimer's disease. Their multimodal AI technology integrates diverse data sources to predict disease trajectory early, enabling better patient stratification ahead of clinical symptoms. This approach supports clinical trials and workflows by identifying the right patients at the right time, aiming to accelerate new treatments and personalize care. Prodromic's AI is designed to be robust, explainable, and trustworthy, addressing the high failure rates and costs in dementia drug development. The company collaborates with clinicians, academics, and pharmaceutical developers to reduce trial costs and improve effectiveness, with a mission to eliminate deaths from Alzheimer's by 2050.
Prodromic
Prodromic is a company focused on early personalized prediction for brain health, specifically targeting neurological conditions like dementia and Alzheimer's disease. Their multimodal AI technology integrates diverse data sources to predict disease trajectory early, enabling better patient stratification ahead of clinical symptoms. This approach supports clinical trials and workflows by identifying the right patients at the right time, aiming to accelerate new treatments and personalize care. Prodromic's AI is designed to be robust, explainable, and trustworthy, addressing the high failure rates and costs in dementia drug development. The company collaborates with clinicians, academics, and pharmaceutical developers to reduce trial costs and improve effectiveness, with a mission to eliminate deaths from Alzheimer's by 2050.